Neuroone Medical Technologies Corp reports results for the quarter ended in September - Earnings Summary

Neuroone Medical Technologies

15/12/2023 15:15

* Neuroone Medical Technologies Corp  NMTC.OQ  reported a
quarterly adjusted loss of 13 cents​​ per share for the quarter
ended in September, lower than the same quarter last year, when
the company reported EPS of -9 cents.  The mean expectation of
two analysts for the quarter was for a loss of 17 cents per
share. Wall Street expected results to range from -18 cents
to -17 cents per share.
    * Revenue rose 975% to $741.78 thousand from a year ago;
analysts
expected $800.00 thousand. 
    * Neuroone Medical Technologies Corp's reported EPS for the
quarter was a loss of 13 cents​.
    * The company reported a quarterly loss of $3.14 million.
    * Neuroone Medical Technologies Corp shares had risen
by 93.2%
this quarter and gained 43.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is  "hold."

Wall Street's median 12-month price target for Neuroone Medical
Technologies Corp is $2.10 
This summary was machine generated from LSEG data December 15 at
03:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.17          -0.13          Beat
 Jun. 30 2023      -0.20          -0.20          Met
 Mar. 31 2023      -0.20          -0.21          Missed
 Dec. 31 2022      -0.11          -0.11          Met